AstraZeneca Drug Shows Promise for Rare Kidney Disease

A breakthrough treatment for a devastating rare kidney condition just moved closer to reality.

AstraZeneca's Ultomiris has shown encouraging results in clinical trials, offering new hope to patients with limited options.